Study Stopped
COVID-19 pandemic
microRNA Testing for Identification of Personalized Weight Management
Efficacy of microRNA Testing for Identification of Personalized Weight Management Strategy in Obese and Overweight Individuals.
1 other identifier
interventional
26
1 country
1
Brief Summary
Certain blood markers are related to one's ability to successfully lose weight by diet and exercise. Currently, the laboratory tests used to measure these blood markers are expensive and time-consuming. Recently, the Electrical and Computer Engineering Department, at NDSU, invented a device that may be able to measure these blood markers much more quickly and affordably. This study is designed participate, to compare our new device to previous methods. If the new sensor is successful, it will be used as diagnostic tool to personalize weight loss strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 2, 2020
CompletedFirst Posted
Study publicly available on registry
January 3, 2020
CompletedStudy Start
First participant enrolled
January 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 4, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedMay 31, 2022
May 1, 2022
4 months
January 2, 2020
May 24, 2022
Conditions
Outcome Measures
Primary Outcomes (6)
micro RNA 140
Venous blood concentrations (M) of micro RNA 140 will be measured using our sensor.
Change across weeks 0, 6, 13
micro RNA 935
Venous blood concentrations (M) of micro RNA 935 will be measured using our sensor.
Change across weeks 0, 6, 13
Body Composition
Change in body composition (% fat) derived from dual x-ray absorptiometry
Change across weeks 0, 6, 13
Lean body mass
Change in lean body mass (kg) derived from dual x-ray absorptiometry
Change across weeks 0, 6, 13
Fat mass
Change in fat mass (kg) derived from dual x-ray absorptiometry
Change across weeks 0, 6, 13
Body mass
Change in body mass (kg) derived from scale
Change across weeks 0, 6, 13
Secondary Outcomes (5)
High-density lipoprotein
Change across weeks 0, 6, 13
Total cholesterol
Change across weeks 0, 6, 13
Triglycerides
Change across weeks 0, 6, 13
Low-density lipoprotein (calculated)
Change across weeks 0, 6, 13
Very low-density lipoprotein (calculated)
Change across weeks 0, 6, 13
Study Arms (1)
500 kcal Energy Deficit
EXPERIMENTALThe goal of the nutrition and exercise intervention will be to induce an energy deficit of approximately 500 kcals/day over the 12-week period in order to induce an approximate 5% weight loss in all participants.
Interventions
The nutrition intervention will be individualized and implemented as a free-living energy-restricted eating plan where energy intake will be based on a mild restriction (approx. 250 kcal/day).
Supervised aerobic exercise will be combined with the energy restriction. Individuals will perform aerobic exercise (treadmill, cycle, or rower or combination) 4-5 days per week for 12 weeks. At each session they will expend 250 or more calories to further meet or exceed the 500 kcal energy deficit.
Eligibility Criteria
You may qualify if:
- generally healthy
- body mass index 25-34.9
- able to do physical activity and exercise
You may not qualify if:
- currently participating in a structured diet or excise program,
- pregnant,
- currently use any nicotine product
- diagnosed neuromuscular disease
- diabetes,
- uncontrolled high blood pressure,
- diagnosed cancer,
- previously had a heart attack or other chronic heart related conditions that are not controlled with medicine
- difficulty moving without assistive devices or walking one-quarter mile
- are taking medications that influence muscle size (testosterone, growth hormone, etc.),
- have had bariatric surgery
- have a body mass greater than 350lbs,
- fear blood, blood draws, or needles
- adverse reaction to a blood draw in the past.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
North Dakota State University
Fargo, North Dakota, 58102, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 2, 2020
First Posted
January 3, 2020
Study Start
January 13, 2020
Primary Completion
May 4, 2020
Study Completion
June 30, 2020
Last Updated
May 31, 2022
Record last verified: 2022-05